redefining role of business analyst in the paradigm of big...

© 2014 BA Convention

Redefining Role of Business Analyst in the paradigm of Big

Data in Healthcare

- Somnath Mukherjee,

General Manager, HCL Technologies Ltd.

© 2014 BA Convention 2

Click to edit Master text styles

Click to edit header

Agenda

A Day in the Life of a BA

Big Data

Pain Point

Frontier for Innovation

Characteristics

Social Intelligence

Case Study

VSDA

Big Data & Business Analyst




A Day in the life of a Business Analyst

Susan, a BA is working with a global team to capture mandate and requirement of a

discovery research lab

Attending a conference

in Florida, she uses her

iPad from her hotel

room.

Hotel / Off-site

Location

She searches the Journal of

Clinical Oncology and finds an

article on predicting overall

survival of treated patients.

After reading she attends few

meetings to discuss business

requirement

Susan’s technical colleagues

review the requirement and get

into meeting with Susan for

clarification

Susan then documents the mandates

and requirements for future

reference.

Susan’s searched various literatures over

internet and studied analyst report to

understand common pain areas and major

information business is looking for

Susan then discuss with user to

get their specific business need

http://www.google.co.in/url?sa=i&rct=j&q=&esrc=s&frm=1&source=images&cd=&cad=rja&uact=8&docid=l0m8pE9Z3aO4FM&tbnid=jLY2fAZ4DXCwwM:&ved=0CAUQjRw&url=http://www.healthcareglobal.com/global_hospitals/cancer-analysts-project-oncology-businesses-to-skyrocket-by-2030&ei=qUN8U9jcLIfIuASotIGIDA&bvm=bv.67229260,d.c2E&psig=AFQjCNGe4_bNgVFnVPvbDpdh7EXyY22Y8w&ust=1400739097624208




Business Pain Points

Increasing demands on

the pharmaceutical

industry

Portfolio

innovation

New emerging

global markets

Personalized

medicine

Continued

profitability

Increased pressure

of proving “real-

world effectiveness

Product Recalls

Greater Scrutiny by FDA

Lack of efficacy

Need for personalized

medicine that has

yielded Low

Productivity in R&D

Investments

Pressure from payer

systems with less

willingness to reimburse

for line extensions and

faster introduction of

generics

Address specific

business points

Challenge in developing

new drugs that meet

patient needs and deliver

demonstrable value

Fewer Blockbuster drugs

despite increasing R&D

budgets

Declining R&D Productivity

Large Pharma is

growing a lot thru

acquisition

Need for quick

redundancy removals

and integration

Improve operating

margins

Large scale investments

in BI tools

Disparate legacy systems

Business Pain Points




BIG Data: Frontier for innovation, competition & productivity Key Insights

Insight #1: Exponential data growth

Insight #2: BIG data creates value in several ways and will be

the basis for competition and growth

Insight #3: Use of BIG data will matter across sectors, some are

poised for greater gains. Similar is the situation on different

geographies.

Insight #6: Emergence of new technology and techniques with

shortage on talent availability

Insight #4: Several issues need to be addressed to capture the

full potential of BIG data

Insight #5: Shift in focal points relative to traditional

BI/Analytics

Creating Transparency

Enabling Experimentation to discover & improve performance

Segmenting population to customize actions

Replacing human decision making with automated systems

Innovating new business models, products & services

Data Policies

Technology and Techniques

organizational change and talent

Access to data

Industry structure

Reference: BIG Data Report – McKinsey and Gartner




Insight View on BIG Data Characteristics

3. Debottleneck

mobile

application

space

$2bn 19%

1. Degree

2. Diversity

3. Distribution

Data Diversity/Variety

Structured

Unstructured

Semi-structured

Audio/Video

Data Distribution

Multi-location

Multi-formats

Multi-files

Data volume as a defining attribute of big

data

Terabytes/ Petabytes

Records / Transactions

Tables / Files

Delivery 4. Data feed mechanism (velocity/speed)

Internet of things

Real time

Near time




Enrich Big Data/ EDW Publish

Web properties Product & services offering Social content Promotions Community connections Much more

Process social content

Text mining Analytics

Data Warehouse Big Data Integration

Analyze

Sources

Web Metrics

Internal Content

External Content

Marketing

Insights Sentiment Opinions Ideas Influencers Events Trends Patterns Exceptions

Enterprise Apps

Aggregated

Syndicate

Connect Customers

People

Products Promotions

BIG Data Reflection Social Intelligence




BIG Data Reflection Social Intelligence

1

2

3 4

5

1) Business: Defines Mandate & Requirement

2) DWH: Acquires & Integrate Data

3) Data Scientist: Build & refine Analytic Model

4) BI: Publishes new insight

5) Business: Consumes insight & measures effectiveness

Technical Team

Business Analyst

Business Analyst Business Analyst

Technical Team

Business Analyst

Business Analyst

Business Goal

Business User

Business User




Distribution of Effort – Big Data Lifecycle

0%

5%

10%

15%

20%

25%

30%

35%

40%

45%

Business

Objective

Data

Manipulation

Data Analysis &

Modeling

Action on

Insights or

Deployment

Learning and

guiding

15% 15% 15%

7% 7%

0%

30%

5% 3% 3%

15%

45%

20%

10% 10%

Business Analyst Technical Team % of Total Effort




• VSDA is a tool that analyses VAERS (Vaccine Adverse Event Reporting System) data to draw out insights on safety of various vaccines in use based on their adverse events (AE) reporting

• The platform can carry out a comparative safety analysis of various vaccines based on the reported AE incidences

• Analysis of vaccine data by this platform could be useful to the pharma companies in decision making process based on its analysis, information and insight generation

• VSDA Tool has features to analyze the data based on multiple KPIs

• The KPIs

1. Geography / State; 2. Age, sex and dose; 3. Site of administration; 4. Symptom count by vaccine and by manufacturer; 5. Specific AE (adverse events) / by vaccine type / vaccine brands / age of vaccination); 6. Co-administered vaccines; 7. By type of vaccine; 8. By manufacturer; 9. By vaccines; 10. Co-administered drugs; 11. Hospitalization and no. of hospital days

• Capabilities

Analysis of data and the results can be presented in a dashboard with statistical representation of data in the form of graphs / charts

Ability to export analytical charts directly into power point presentations

Wh

at is

VSD

A

Cap

abili

tie

s &

KP

Is

Vaccine Safety Data Analyzer (VSDA)




Key Business Questions: 1. How many adverse events were reported due to BCG vaccine between 2006 -2011? 2. What was the geographical location of such AEs in United States? 3. How many of the adverse events lead to hospitalization and for many days?

• Between 2006 -2011, 229 cases of adverse events reported due to BCG vaccine, 18% of which were from region around the Great Lakes.

• None of the adverse events resulted in any Hospital days or hospitalization.

Vaccine

Geographical Distribution

of AEs

Hospitalization and

Hospital Days

Insights

VSDA Snapshot - Adverse Event Analysis by Geography




Business Analyst – Change in Definition

The role of a Business Analyst can also be defined as a media to capture and document the

business problems and pass on the same to the technology solutions group.

Business Technology

Old Definition

Solution

Business

Analyst Technical

Lead




Business Analyst – Change in Definition

The role of a Business Analyst can also be defined as a bridge between the business problems

and the technology solutions.

Business Technology

New Definition

Solution

Business

Analyst

Technical

Lead




Role of a Traditional Business Analyst

Understand what

the Business

Does and how it

does it

Determine how

to improve

existing business

processes

Determine which

task/steps to

automate (Gather

Requirement)

Design the

feature of IT

System (Create

Functional

Specification)

Implement the

new features of IT

system (technical

design)

Traditional Business Analyst

Business Process Analyst

IT Business Analyst

System Analyst

Specific

Roles

Requirement Engineer (Analyst)

Business Systems Analyst

Business Analyst

Title




Functions of Business Analyst in Analytics space

A Guide to the Business Analysis Body of Knowledge®

(BABOK® Guide) incorporates six Knowledge Areas

along with a set of underlying competencies, and

applies to both the enterprise and to projects. The

knowledge areas are:

Business Analysis Planning and Monitoring (BAP&M)

Elicitation (E)

Requirements Management and Communication (RM&C)

Enterprise Analysis (EA)

Requirements Analysis (RA)

Solution Assessment and Validation (SA&V)




Business Analysis 3i Framework B

AP

&M

R

M&

C

E EA

R

A

SA&

V

Sources Process Social Content Analyze Enrich BIG DATA Publish Inference

Identification of KPI

Business Requirement

Planning

External Content Web Metrics Pharmacy Lab Internal Content

Enterprise Apps Marketing

Data Model Data Mining What/if Analysis

Simulation

Decision Analysis

Requirement Capture

Brainstorming Data Model Interview Interface

Identification Observation

Retrospective Process Model Metrics & Reporting

User Profiling

Change Control System

Configuration Management

Coverage Metrics

Issue & Defect Reporting

Structured Walkthrough

Cost/Benefit Analysis

Prediction

Data Model Business Rule GAP Analysis Decomposition Interface Analysis

Process Model

Structured Walkthrough

Traceability Matrix

Decision Analysis

Retrospective Analysis

Co

llabo

ration

Information Interaction Intelligence

Reference: BABok 2.0 Framework

© 2014 BA Convention

Learn more. www.baconvention.com

Thank You!

For more information please reach out to Somnath Mukherjee

[email protected]

mailto:[email protected]




Key Business Questions: 1. What are the major symptoms reported in analysis of adverse events due to vaccines from 2006 -2012? 2. Which vaccines gave the highest % of “injection site erythema” as adverse event? 3. Which manufacturer’s vaccine was responsible for highest incidence of injection site erythema?

• Between 2006 -2011, 18.2% of Injection site erythema were caused due to FLU vaccines. • 47.2% of the FLU vaccines that caused injection site erythema were manufactured by Company B

Major AE of Interest

VACCINE

Manufacturer

Insights

VSDA Snapshot - Adverse Event Analysis by Vaccine




Key Business Questions: 1. What were the number of AE reported per manufacture from 2006 -2011? 2. Which “Flu” manufacturer had the highest % of adverse events between 2006 – 2011? 3. Which “Flu” manufacturer’s vaccine was responsible for least incidence of adverse events?

• Between 2006 -2011, 71.6% of total reported AE were due to vaccines manufacturer by Company A , B and C. • Approx. 39% of AE reported for Company A were for HPV, whereas Flu vaccines accounted for ~49% of reported AEs for Company B.

Manufacturer

VACCINE

AE Count

Insights

VSDA Snapshot - Adverse Event Analysis by Manufacturer

redefining role of business analyst in the paradigm of big...

Documents